Eagle Pharmaceuticals, Inc.

Ownership Transactions Reported by 9 Insiders

Symbol
EGRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
50 Tice Boulevard, Suite 315, Woodcliff Lake, NJ

There are no Buy or Sell transactions made by insiders since 11/5/2023

Eagle Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Scott Tarriff 10%+ Owner $9.11M Feb 28, 2024
Brian Cahill Chief Financial Officer $309K Feb 27, 2024
Michael Shawn Moran EVP, Chief Commercial Officer $165K Feb 28, 2022
Michael Graves Interim Executive Chair & PEO, Director $53.1K Dec 21, 2023
Steven B. Ratoff Director Mar 7, 2023
Richard A. Edlin Director Mar 7, 2023
Luciana Borio Director Mar 7, 2023
Jennifer K. Simpson Director Mar 7, 2023
Robert Glenning Director Mar 7, 2023

Recent Insider Transactions by Companies or Individuals for Eagle Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.